TNFSF11 and postmenopausal osteoporosis: An imbalance at the RANKL:OPG ratio caused by abundant RANKL levels is believed to be a major determinant in the development of bone loss diseases, including postmenopausal osteoporosis, a metabolic bone disease characterized by decreased bone density and increased fracture risk (9).